Promoting Standardization of Clinical Evidence With Severity-Guided Treatments for Idiopathic Granulomatous Mastitis: A Narrative Review.
| Autor: | Gillen N; Prisma Health Greenville Memorial Medical Campus, Greenville, SC, USA., Leahy J; Surgical Clerkship Director, Florida State University College of Medicine, Pensacola, FL, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The American surgeon [Am Surg] 2025 Jan; Vol. 91 (1), pp. 133-140. Date of Electronic Publication: 2024 Aug 22. |
| DOI: | 10.1177/00031348241275717 |
| Abstrakt: | Idiopathic granulomatous mastitis (IGM) is a benign disease of the breast which causes a great deal of discomfort for patients. More comparable data and greater consensus in treatment are needed to better understand the disease and help with evidence-based clinical decision making. This narrative review aims to discuss the literature available on IGM and illustrate the need for consensus on treatment. We highlight the existing severity scores for this disease in the literature and discuss the value of severity-guided treatment. In our review, 81 studies out of 319 reviewed publications met established criteria. With the selected results from our search results, the available research on IGM etiology, risk factors, diagnosis, and treatment is summarized with an emphasis on the existing severity scores. A total of four proposed severity scores were found in our review. Consensus on the treatment of IGM must be established. There are varying severity scores on IGM severity. We suggest using an established standardized severity score to guide treatment and recommend one such score. Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. FundingThe author(s) received no financial support for the research, authorship, and/or publication of this article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|